
For investors targeting Sarepta Therapeutics Inc (SRPT) shares, selling a $17.50 strike put offers an effective entry cost of $15.80 and a potential 9.71% premium yield (70.91% annualized) if the option expires worthless. Alternatively, a covered call strategy utilizing a $19.00 strike call can generate a 17.73% total return if shares are called away, or a 10.45% premium boost (76.26% annualized) if the call expires worthless. Both strategies are presented in the context of SRPT's implied volatilities (111% for puts, 120% for calls) against a 104% historical volatility.
The options market for Sarepta Therapeutics (SRPT) currently presents notable opportunities for premium generation, driven by an implied volatility of 111%-120% that exceeds the stock's trailing twelve-month actual volatility of 104%. For investors considering initiating a position, selling the $17.50 strike put contract at a $1.70 premium offers an effective entry point at a cost basis of $15.80, a significant discount to the current share price of $17.71. This strategy carries a 61% statistical probability of expiring worthless, which would result in a 9.71% return on cash collateral (70.91% annualized). For existing shareholders, a covered call strategy using the $19.00 strike can generate immediate income via a $1.85 premium. This approach yields a total potential return of 17.73% if the stock is called away, or a 10.45% yield enhancement (76.26% annualized) if the option expires out-of-the-money, for which analytics suggest a 45% probability. Both strategies are purely technical plays on volatility and price levels, divorced from the company's underlying business fundamentals.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment